Herbal Medicines for Dementia and Alzheimer’s Disease

Editors: Sachin Kumar Jain, Kratika Daniel, Sudha Vengurlekar

Herbal Medicines for Dementia and Alzheimer’s Disease

ISBN: 979-8-89881-553-0
eISBN: 979-8-89881-552-3 (Online)

Introduction

Herbal Medicines for Dementia and Alzheimer’s Disease offers a comprehensive exploration of traditional and contemporary approaches to managing neurodegenerative disorders like Alzheimer’s disease and dementia. The book examines how herbal medicine, nootropics, and complementary therapies can contribute to cognitive health, memory enhancement, and neuroprotection. It integrates foundational neuroscience with phytopharmacology to provide a holistic understanding of cognition-related disorders and their management strategies.

The book begins with an introduction to memory function and neurodegenerative diseases, followed by an overview of Alzheimer’s disease and dementia, highlighting their pathological mechanisms and clinical progression. It then explores the concept of nootropics and smart drugs, providing insight into cognitive enhancers and their relevance in modern neuroscience. A major section is dedicated to herbal drugs and their active phytoconstituents, emphasising plant-based compounds used in the prevention and treatment of cognitive decline. Additional chapters discuss non-herbal complementary therapies, Ayurvedic preparations as cognition enhancers, and integrative approaches that extend beyond conventional pharmacotherapy.

The book also includes methodological and applied perspectives, covering in-vitro and in vivo pharmacological screening methods used in Alzheimer’s research. It addresses critical safety considerations through discussions on herb–drug and food–drug interactions, ensuring a balanced understanding of efficacy and risk. Contemporary research evidence, clinical studies, and emerging therapeutic trends are also presented to bridge the gap between traditional knowledge and modern scientific validation. The concluding chapters highlight future directions in herbal medicine and cognitive enhancement strategies, including evolving roles of nootropics in brain health.


Key Features

  • - Comprehensive coverage of Alzheimer’s disease and dementia from a neurobiological and therapeutic perspective.
  • - Detailed discussion on herbal medicines and bioactive phytoconstituents for cognitive enhancement.
  • - Inclusion of Ayurvedic formulations and traditional cognition-enhancing systems with focus on nootropics, smart drugs, and complementary non-pharmacological therapies.
  • - Practical insights into in-vitro and in-vivo pharmacological screening methods with critical analysis of herb–drug and food–drug interactions for safety awareness.
  • - Integration of clinical studies, research evidence, and emerging therapeutic approaches.

Target Readership :

This book is intended for undergraduate and postgraduate students in pharmacy, pharmacology, neuroscience, biotechnology, and medical sciences, while also serving as a valuable resource for researchers, clinicians and other professionals in cognitive disorders and integrative approaches to brain health.

Foreword

The overarching goal of public health is to protect and improve the health of individuals, families, communities, and populations, locally and globally. In collaboration with physicians, nurses, and other healthcare professionals, pharmacists have an incredible opportunity and the skills to contribute toward this goal. In recent years, the role of public health education and training within the profession of pharmacy has been formalized for students and practicing pharmacists alike. Pharmacy curricula, as part of accreditation requirements, are required to design programs that achieve educational outcomes in population-based care, cultural sensitivity, interprofessional collaboration, and health and wellness.

In an effort to further these goals, the following casebook was developed. While a number of public health pharmacy educational texts are available, there is currently a paucity of resources that focus on the application of public health knowledge in a case-based format for pharmacists. Casebooks in health sciences allow opportunity for students to work toward educational competencies through patient-oriented scenarios prior to or in concert with formal clinical experiences.

The facts and numbers about Alzheimer’s disease (AD) can be hard to fathom: over 5 million living with AD in the US alone, the 6th leading cause of death, a $300 billion cost in 2020 that projects to $1.1 trillion by 2050. To the 16 million caregivers of AD patients, however, the numbers become all too real and can be the challenge of their lives. The afflicted no longer recognize us, and we no longer recognize them. Familiar loved ones become strangers. Their utter dependence, coupled with our sense of duty, taints our fond memories with bitterness and resentment.

In many ways, AD is also the existential fight of our lives as human beings. The human brain is a pinnacle of evolutionary achievement, with the cognition it enables (i.e., its abilities to feel, think, and learn) being the highest expression of this evolution. Thus, AD cuts straight to the core of what it means to be human. As a society, why are not we closer to understanding AD and having a cure? Since the 1980s, the US government, through its National Institutes of Health (NIH), has developed an impressive network of AD research centers, now more than 30 strong, which includes a coordinating center (National Alzheimer’s Coordinating Center) and consortia to combine patient data and get the best minds together to figure out the genetics (AD Genetics Consortium).

There is significant potential in discovering drugs based on plant extracts. Plants such as Ginkgo biloba, Ashwagandha, and Ginseng have beneficial effects on brain health and the nervous system, which may lead to improvements in memory and concentration, and a reduction in dementia symptoms.


Sanyam Gandhi
Senior Regulatory Lead Takeda
Pharmaceutical 500 Kendall St Cambridge
MA, USA